The kinetics of a memory B cell response to virus like particles in mice

The kinetics of a memory B cell response to virus like particles in mice

Bibliographic Details
Main Authors:	Zabel, F, Mohanan, D, Link, A, Bessa, J, Saudan, P, Kuendig, T, Bachmann, M
Format:	Journal article
Published:	2012

Similar Items

Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies
by: Zabel, F, et al.
Published: (2014)

Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies.
by: Zabel, F, et al.
Published: (2014)

Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses.
by: Bessa, J, et al.
Published: (2012)

B cell TLRs and the antibody response to virus particles
by: DeFranco, A, et al.
Published: (2011)

Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines.
by: Gomes, A, et al.
Published: (2017)

Bacterially produced recombinant influenza vaccines based on virus-like particles
by: Jegerlehner, A, et al.
Published: (2013)

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.
by: Jegerlehner, A, et al.
Published: (2010)

Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
by: Bründler, M, et al.
Published: (1996)

Virus-induced humoral immunity: on how B cell responses are initiated.
by: Zabel, F, et al.
Published: (2013)

Virus-induced humoral immunity: On how B cell responses are initiated
by: Zabel, F, et al.
Published: (2013)

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
by: Bessa, J, et al.
Published: (2008)

Virus-like particles induce robust human T-helper cell responses.
by: Braun, M, et al.
Published: (2012)

Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particles.
by: Gatto, D, et al.
Published: (2007)

Versatile virus-like particle carrier for epitope based vaccines
by: Tissot, A, et al.
Published: (2010)

The coming of age of virus-like particle vaccines.
by: Jennings, G, et al.
Published: (2008)

Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life span.
by: Gatto, D, et al.
Published: (2007)

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
by: Storni, T, et al.
Published: (2002)

Toll-like receptor 7 signaling drives IgA responses
by: Bessa, J, et al.
Published: (2007)

Virus-like particle vaccines
by: Mukhopadhyay, E, et al.
Published: (2022)

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.
by: Ruedl, C, et al.
Published: (2005)

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.
by: Schmitz, N, et al.
Published: (2009)

Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner.
by: Bessa, J, et al.
Published: (2010)

Use of virus-like particles for therapeutic vaccination against addiction and other chronic diseases
by: Bachmann, M
Published: (2005)

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses.
by: Bessa, J, et al.
Published: (2009)

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.
by: Schwarz, K, et al.
Published: (2005)

Rapid response of marginal zone B cells to viral particles.
by: Gatto, D, et al.
Published: (2004)

T-cell-independent antiviral B cell responses in CD45-deficient mice.
by: Bachmann, M, et al.
Published: (1997)

Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells.
by: Engeroff, P, et al.
Published: (2017)

T cell-dependent and -independent IgA responses: role of TLR signalling.
by: Bessa, J, et al.
Published: (2010)

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection.
by: Kopf, M, et al.
Published: (1999)

Virus-like particles as a modular system for novel vaccines.
by: Lechner, F, et al.
Published: (2002)

Chimeric virus-like particles of prawn nodavirus displaying hepatitis B virus immunodominant region: biophysical properties and cytokine response
by: Ninyio, Nathaniel Nyakaat, et al.
Published: (2021)

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
by: Klimek, L, et al.
Published: (2014)

Cytokine production by peripheral blood cells following therapy with a combined vaccine of allergen and QbG10
by: Manolova, V, et al.
Published: (2008)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
by: Klimek, L, et al.
Published: (2018)

Virus-like particles as vaccine adjuvants.
by: Gilbert, S
Published: (2001)

Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses
by: Alam, Mohammad Murshid, et al.
Published: (2022)

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.
by: Hou, B, et al.
Published: (2011)

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
by: Zeltins, A, et al.
Published: (2017)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
by: Doucet, M, et al.
Published: (2017)